VEGFA Antikörper (Vascular Endothelial Growth Factor A) (AA 140-168)

Details for Product anti-VEGFA Antibody No. ABIN2385150
Target
Bindungsspezifität
AA 140-168, Internal Region
17
16
16
15
8
8
7
7
7
7
7
6
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
206
108
105
34
31
23
20
11
7
5
4
4
4
4
3
3
3
3
1
1
1
Wirt
Kaninchen
192
75
19
1
1
1
1
Klonalität
Polyklonal
Konjugat
Dieser VEGFA Antikörper ist unkonjugiert
45
26
11
4
4
4
4
3
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Applikation
ELISA, Western Blotting (WB)
198
126
64
47
35
26
24
18
16
14
14
13
11
9
7
6
3
2
1
1
1
1
Optionen
Immunogen KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 140-168 in the Central region of human VEGFA, UniProt Accession #NP_001020537.
Isotyp IgG
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VEGFA, ID (VEGFA, VEGF, Vascular endothelial growth factor A, Vascular permeability factor)
Reinigung Purified by Protein A affinity chromatography.
Target
Andere Bezeichnung VEGFA (VEGFA Antibody Abstract)
NCBI Accession NP_001020537, NP_001020538
UniProt P15692
Pathways RTK Signalweg, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung -20°C